Nuveen Asset Management, LLC Aspira Women'S Health Inc. Transaction History

Nuveen Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $108,674 - $296,137	-271,686 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.88 - $1.81 $42,891 - $88,219	-48,740 Reduced 15.21%	271,686 $288,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.43 $72,924 - $153,454	44,739 Added 16.23%	320,426 $567,000
Q3 2021 Nov 12, 2021	SELL	$3.19 - $5.48 $41,166 - $70,719	-12,905 Reduced 4.47%	275,687 $1.01 Million
Q2 2021 Aug 16, 2021	SELL	$4.78 - $6.84 $207,428 - $296,821	-43,395 Reduced 13.07%	288,592 $1.62 Million

Q1 2021 May 17, 2021	BUY	$5.9 - $9.13 $186,900 - $289,220	31,678 Added 10.55%	331,987 $2.24 Million
Q4 2020 Feb 16, 2021	BUY	$3.0 - $6.71 $78,693 - $176,010	26,231 Added 9.57%	300,309 $2.02 Million
Q3 2020 Nov 16, 2020	BUY	$2.54 - $4.56 $274,353 - $492,539	108,013 Added 65.04%	274,078 $846,000
Q2 2020 Aug 14, 2020	BUY	$0.78 - $5.25 $129,530 - $871,841	166,065 New	166,065 $638,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $185M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.